Drugs / Nonoxynol-9

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) DELFEN — 1963-12-10 fda.gov ↗

Trials 4

196319641965196619671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT02545452 Sep 2015 → Mar 2016 endometriosis Bayer Completed No outcome recorded
Phase 1 NCT00000929 ? → Jul 1999 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT00578877 Jan 2008 → Oct 2009 — CONRAD Completed No outcome recorded
Phase 31 trial
Phase 3 NCT00000926 ? → Feb 2001 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Comparator or background therapy5 trials
Phase 0 NCT00389311 Comparator Apr 2007 → Feb 2008 HIV infectious disease Johns Hopkins University Completed No outcome recorded
Phase 1 NCT01232803 Comparator Oct 2010 → Jul 2011 — CONRAD Completed No outcome recorded
Phase 2 NCT01593124 Comparator May 2012 → Apr 2013 infective vaginitis CONRAD Completed No outcome recorded
Phase 2 NCT00692952 Comparator Mar 2004 → Nov 2005 — Shanghai Institute of Planned Parenthood Research Completed No outcome recorded
Phase 3 NCT01306331 Comparator Apr 2011 → Jun 2014 — Evofem Inc. Completed No outcome recorded

Press releases naming this drug 86 releases

DateIssuerRelease
2026-09-11 Prelude Therapeutics Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference preludetx.com ↗
2026-09-10 Prelude Therapeutics Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader preludetx.com ↗
2026-08-11 Prelude Therapeutics Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update preludetx.com ↗
2026-05-12 Prelude Therapeutics Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update preludetx.com ↗
2026-04-20 Prelude Therapeutics Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at American Association for Cancer Research (AACR) Annual Meeting 2026 preludetx.com ↗
2026-04-20 Prelude Therapeutics Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering preludetx.com ↗
2026-04-15 Prelude Therapeutics Prelude Therapeutics Announces the Appointment of Charles Morris, M.D. as Chief Medical Officer preludetx.com ↗
2026-03-17 Prelude Therapeutics Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting preludetx.com ↗
2026-03-10 Prelude Therapeutics Prelude Therapeutics Reports Full Year 2025 Financial Results and Provides Program Outlook for 2026 preludetx.com ↗
2026-02-03 Prelude Therapeutics Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application (IND) for PRT12396, a Mutant-selective JAK2V617F Inhibitor preludetx.com ↗
2025-12-06 Prelude Therapeutics Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs preludetx.com ↗
2025-11-12 Prelude Therapeutics Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update preludetx.com ↗

Evidence & citations 26 cited values

Every value below carries the sentence it was read from. 11 sources stand behind the page.

FieldValueCited text
Known as nonoxynol-9 “Conceptrol® Vaginal Gel, which contains 100 mg (4% concentration) of nonoxynol-9 (N-9) in 2.5 mL volume of gel.” NCT01306331 ↗
8

“75 mg Nonoxynol-9 per day for 3 consecutive days” NCT02545452 ↗

“a 2% nonoxynol-9 gel” PMID 23573238 ↗ Apr 2013

NCT00000929 ↗

NCT01593124 ↗

NCT00000926 ↗

NCT00692952 ↗

NCT00389311 ↗

NCT00578877 ↗

Known as C-film ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Col-1492 ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Delfen ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Double check ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Duragel ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Emko ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Gygel ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Gynol 11 ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Igepal co-630 ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as LELEMI “LELEMI® contraceptive gel containing 50mg nonoxynol-9” NCT00692952 ↗
Known as N-9 “Ten subjects received 3 one-time interventions: 5 mL of Normosol-R fluid alone (negative control), 5 mL of 2% nonoxynol-9 (N-9) gel, and 5 mL of Normosol-R with coital...” PMID 23325915 ↗ Jan 2013
2

“Conceptrol® Vaginal Gel, which contains 100 mg (4% concentration) of nonoxynol-9 (N-9) in 2.5 mL volume of gel.” NCT01306331 ↗

“A Study of Nonoxynol-9 (N-9) and HIV Infection” NCT00000926 ↗

Known as Nonoxinol 9 ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Nonoxinolum 9 ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Nonoxynol-9.5 ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Nonylphenoxypolyethoxyethanol ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Norfox np-9 ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as NSC-758941 ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Ortho-creme ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Ortho-forms ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Peg-9 nonyl phenyl ether ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Prelude ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Tergitol np-9 ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Known as Today ChEMBL registry synonym — accepted as the source's own label CHEMBL1410 ↗
Modality Small molecule — CHEMBL1410 ↗